News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/Motzer_Robert_J_NYC_web.jpg)
PROTECT: Pazopanib falls short as adjuvant therapy for high-risk RCC
- Author:
- Susan London
CHICAGO – In a phase III randomized controlled trial of more than 1,500 patients who had undergone nephrectomy for high-risk locally advanced RCC...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/126308_Zaid_Abu_IN_web.jpg)
Hypogonadism after testicular cancer treatment can have lifelong impact
- Author:
- Susan London
CHICAGO – Men with low testosterone in a cohort study of 491 testicular cancer survivors were more likely to be taking medications for...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/Robson_Mark_E_NY_web.jpg)
OlympiAD’s positive results spell good news for olaparib in breast cancer
- Author:
- Susan London
CHICAGO – The OlympiAD trial represents a “major step forward in breast cancer” in terms of both translational medicine and precision medicine.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/Hyman_David_New York_web.jpg)
TRK inhibitor shows ‘striking’ activity, durability across diverse adult and pediatric cancers
- Author:
- Susan London
An analysis of three trials involving 55 patients with advanced cancer harboring TRK fusions who were treated with larotrectinib showed an overall...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/robson.jpg)
VIDEO: Olaparib improves outlook in women with BRCA-related HER2-negative MBC
- Author:
- Susan London
In phase III results, olaparib reduced the risk of progression or death in women with BRCA-related HER2-negative metastatic breast cancer,...
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/hyman.jpg)
VIDEO: TRK inhibitor shows 76% ORR across diverse cancers harboring TRK fusions
- Author:
- Susan London
CHICAGO – Lead study investigator David Hyman, MD, discusses the integrated analysis of three larotrectinib trials and the drug’s regulatory...
News
Single-dose RT suffices for treatment of spinal cord compression due to mets
- Author:
- Susan London
CHICAGO – “A single dose has enormous advantages in those patients with short survival times.”
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/abu_said.jpg)
VIDEO: Low testosterone common after testicular cancer
- Author:
- Susan London
CHICAGO – Survivors with hypogonadism are more likely than survivors with normal testosterone levels to have a range of chronic health problems....
Video
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/June-2017/hoskin.jpg)
VIDEO: Single dose of RT suffices, but will radiation oncologists adopt the strategy?
- Author:
- Susan London
A single dose of radiation therapy works essentially as well as multiple doses for treating spinal cord compression resulting from cancer...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Stroke_1_web.jpg)
Infections up the risk for pregnancy-associated stroke in preeclampsia
- Author:
- Susan London
A study in a diverse population of pregnant women with preeclampsia has identified several risk factors for pregnancy-associated stroke.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Vaccine_HPV_web_0_0.jpg)
Oral HPV infections sharply lower for vaccinated youth
- Author:
- Susan London
HPV vaccination appears to confer a high level of protection against oral infection with oncogenic virus types.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Nuts_tree_web.jpg)
Healthy lifestyle, tree nuts may protect against colon cancer recurrence
- Author:
- Susan London
Patients with treated early colon cancer who follow a healthy lifestyle and include tree nuts in their diet are less likely to experience...
News
Gefitinib bests chemo as adjuvant therapy for early EGFR-mutant NSCLC
- Author:
- Susan London
Gefitinib is superior to the standard of care chemotherapy for treatment of resected early non–small cell lung cancer harboring an EGFR activating...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Primrose_John_N_web.jpg)
BILCAP: adjuvant capecitabine boosts overall survival of biliary tract cancers
- Author:
- Susan London
Patients who have undergone complete resection of biliary tract cancers live longer if they receive the oral chemotherapy agent capecitabine...
News
More early-stage cancer diagnosis since ACA implementation
- Author:
- Susan London
Though the increase is small, cancer has been detected earlier and more often, indicating future improvements in care.